These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25939300)

  • 21. [Evaluation of cardiovascular risk in HIV positive patients in a specialized center at Santiago, Chile].
    Lazcano C; Millacura JC; Saavedra F; Cortés CP
    Rev Chilena Infectol; 2016 Jun; 33(3):352-4. PubMed ID: 27598289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of human immunodeficiency virus in primary care.
    Sell JK
    Prim Care; 2013 Sep; 40(3):589-617. PubMed ID: 23958359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation and pharmacologic management of the HIV-infected patient with dyslipidemia.
    Hardwicke RL; Lewis ST; Grimes RM
    J Assoc Nurses AIDS Care; 2010; 21(5):429-38. PubMed ID: 20303794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disorders of glucose metabolism in human immunodeficiency virus-infected patients.
    Benhalima K; Mathieu C; Van Wijngaerden E
    Acta Clin Belg; 2008; 63(4):227-34. PubMed ID: 19048699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How should HIV patients lower lipid levels?
    Brown BR
    HIV Clin; 2000; 12(3):1, 6-8. PubMed ID: 11810836
    [No Abstract]   [Full Text] [Related]  

  • 26. LIPID abnormalities in patients infected with human immunodeficiency virus.
    Mikhail NE
    Endocr Pract; 2008; 14(4):492-500. PubMed ID: 18558606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV and the body: a review of multidisciplinary management.
    Rockstroh J; Guaraldi G; Deray G
    HIV Med; 2010 Sep; 11 Suppl 2():1-8. PubMed ID: 20929492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dyslipidemia in menopause: mechanisms and management.
    Schnatz PF; Schnatz JD
    Obstet Gynecol Surv; 2006 Sep; 61(9):608-13. PubMed ID: 16919179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managing the dyslipidemia of metabolic syndrome: beyond statin therapy.
    Jialal I; Smith G
    Metab Syndr Relat Disord; 2012 Jun; 10(3):159-60. PubMed ID: 22568574
    [No Abstract]   [Full Text] [Related]  

  • 31. Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics.
    Tarr PE; Rotger M; Telenti A
    Pharmacogenomics; 2010 Apr; 11(4):587-94. PubMed ID: 20350140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular disease in HIV infection.
    Sánchez-Torres RJ; García-Palmieri MR
    P R Health Sci J; 2006 Sep; 25(3):249-54. PubMed ID: 17203795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The management of dyslipidaemias in antiretroviral-treated HIV infection: a systematic review.
    McGoldrick C; Leen CL
    HIV Med; 2007 Sep; 8(6):325-34. PubMed ID: 17661840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of metabolic complications and cardiovascular risk in HIV-infected patients.
    Blanco F; San Román J; Vispo E; López M; Salto A; Abad V; Soriano V
    AIDS Rev; 2010; 12(4):231-41. PubMed ID: 21179187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipidome Abnormalities and Cardiovascular Disease Risk in HIV Infection.
    Bowman E; Funderburg NT
    Curr HIV/AIDS Rep; 2019 Jun; 16(3):214-223. PubMed ID: 30993515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary heart disease in people infected with HIV.
    Malvestutto CD; Aberg JA
    Cleve Clin J Med; 2010 Aug; 77(8):547-56. PubMed ID: 20682517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
    Boccara F
    AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular disease prevention and treatment in patients with human immunodeficiency virus.
    Magen E; Elbirt D; Sthoeger Z
    Isr Med Assoc J; 2005 Apr; 7(4):252-6. PubMed ID: 15847207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular implications of HIV-induced dyslipidemia.
    Giannarelli C; Klein RS; Badimon JJ
    Atherosclerosis; 2011 Dec; 219(2):384-9. PubMed ID: 21722900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human immunodeficiency virus and renal transplantation.
    Dinavahi RV; Mehrotra A; Murphy BT; Huprikar S
    Kidney Int; 2009 Oct; 76(8):907-10. PubMed ID: 19494802
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.